Clinical Trial: A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia Patients

U.S., June 13 -- ClinicalTrials.gov registry received information related to the study (NCT07644351) titled 'A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia Patients' on June 08.

Brief Summary: The aim of this study was to collect existing information from the medical charts of patients enrolled in the ongoing asciminib Managed Access Program (MAP) to better understand the effectiveness and safety of asciminib when used to treat adult patients with Ph+ ALL who are refractory, resistant or intolerant to available treatments.

Study Start Date: Dec. 16, 2024

Study Type: OBSERVATIONAL

Condition: Acute Lymphoblastic Leukemia

Recruitment Status: COMPLETED

Sponsor: Novartis Pharmaceuticals...